Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Hafström I[au]:

Search results

Items: 1 to 50 of 100

1.

A Swedish register-based, long-term inception cohort study of patients with rheumatoid arthritis - results of clinical relevance.

Hafström I, Ajeganova S, Andersson ML, Bala SV, Bergman S, Bremander A, Forslind K, Malm K, Svensson B.

Open Access Rheumatol. 2019 Sep 9;11:207-217. doi: 10.2147/OARRR.S218448. eCollection 2019.

2.

Widespread pain and pain intensity in patients with early rheumatoid arthritis. A cross-sectional comparison between smokers and non-smokers.

Karlsson ML, Elkan AC, Hafström I.

Nurs Open. 2019 Apr 21;6(3):942-947. doi: 10.1002/nop2.284. eCollection 2019 Jul.

3.

Anti-citrullinated protein antibodies are associated with osteopenia but not with pain at diagnosis of rheumatoid arthritis: data from the BARFOT cohort.

Hafström I, Ajeganova S, Forslind K, Svensson B.

Arthritis Res Ther. 2019 Feb 4;21(1):45. doi: 10.1186/s13075-019-1833-y.

4.

Obesity is a strong predictor of worse clinical outcomes and treatment responses in early rheumatoid arthritis: results from the SWEFOT trial.

Levitsky A, Brismar K, Hafström I, Hambardzumyan K, Lourdudoss C, van Vollenhoven RF, Saevarsdottir S.

RMD Open. 2017 Aug 9;3(2):e000458. doi: 10.1136/rmdopen-2017-000458. eCollection 2017.

5.

Patients with Early Rheumatoid Arthritis in the 2000s Have Equal Disability and Pain Despite Less Disease Activity Compared with the 1990s: Data from the BARFOT Study over 8 Years.

Andersson MLE, Forslind K, Hafström I; BARFOT Study Group.

J Rheumatol. 2017 Jun;44(6):723-731. doi: 10.3899/jrheum.161235. Epub 2017 Apr 1.

PMID:
28365578
6.

Rheumatoid arthritis phenotype at presentation differs depending on the number of autoantibodies present.

Derksen VF, Ajeganova S, Trouw LA, van der Helm-van Mil AH, Hafström I, Huizinga TW, Toes RE, Svensson B, van der Woude D.

Ann Rheum Dis. 2017 Apr;76(4):716-720. doi: 10.1136/annrheumdis-2016-209794. Epub 2016 Nov 9.

PMID:
28283528
7.

Smoking is associated with the concurrent presence of multiple autoantibodies in rheumatoid arthritis rather than with anti-citrullinated protein antibodies per se: a multicenter cohort study.

van Wesemael TJ, Ajeganova S, Humphreys J, Terao C, Muhammad A, Symmons DP, MacGregor AJ, Hafström I, Trouw LA, van der Helm-van Mil AH, Huizinga TW, Mimori T, Toes RE, Matsuda F, Svensson B, Verstappen SM, van der Woude D.

Arthritis Res Ther. 2016 Dec 1;18(1):285.

8.

Dietary micronutrient intake and atherosclerosis in systemic lupus erythematosus.

Lourdudoss C, Elkan AC, Hafström I, Jogestrand T, Gustafsson T, van Vollenhoven R, Frostegård J.

Lupus. 2016 Dec;25(14):1602-1609. Epub 2016 Jun 22.

PMID:
27334936
9.

Persistently active disease is common in patients with rheumatoid arthritis, particularly in women: a long-term inception cohort study.

Svensson B, Andersson M, Forslind K, Ajeganova S, Hafström I; BARFOT study group.

Scand J Rheumatol. 2016 Nov;45(6):448-455. Epub 2016 Apr 20.

PMID:
27095008
11.

The association between anti-carbamylated protein (anti-CarP) antibodies and radiographic progression in early rheumatoid arthritis: a study exploring replication and the added value to ACPA and rheumatoid factor.

Ajeganova S, van Steenbergen HW, Verheul MK, Forslind K, Hafström I, Toes RE, Huizinga TW, Svensson B, Trouw LA, van der Helm-van Mil AH.

Ann Rheum Dis. 2017 Jan;76(1):112-118. doi: 10.1136/annrheumdis-2015-208870. Epub 2016 Apr 26.

PMID:
27117699
12.

IgM antibodies against malondialdehyde and phosphorylcholine are together strong protection markers for atherosclerosis in systemic lupus erythematosus: Regulation and underlying mechanisms.

Rahman M, Sing S, Golabkesh Z, Fiskesund R, Gustafsson T, Jogestrand T, Frostegård AG, Hafström I, Liu A, Frostegård J.

Clin Immunol. 2016 May;166-167:27-37. doi: 10.1016/j.clim.2016.04.007. Epub 2016 Apr 19.

PMID:
27102765
13.

The association between diet and glucocorticoid treatment in patients with SLE.

Lourdudoss C, Hafström I, Frostegård J, van Vollenhoven R.

Lupus Sci Med. 2016 Jan 27;3(1):e000135. doi: 10.1136/lupus-2015-000135. eCollection 2016.

14.

Anticitrullinated protein antibodies and rheumatoid factor are associated with increased mortality but with different causes of death in patients with rheumatoid arthritis: a longitudinal study in three European cohorts.

Ajeganova S, Humphreys JH, Verheul MK, van Steenbergen HW, van Nies JA, Hafström I, Svensson B, Huizinga TW, Trouw LA, Verstappen SM, van der Helm-van Mil AH.

Ann Rheum Dis. 2016 Nov;75(11):1924-1932. doi: 10.1136/annrheumdis-2015-208579. Epub 2016 Jan 12.

PMID:
26757747
15.

Bone mineral density and carotid atherosclerosis in systemic lupus erythematosus: a controlled cross-sectional study.

Ajeganova S, Gustafsson T, Jogestrand T, Frostegård J, Hafström I.

Arthritis Res Ther. 2015 Mar 25;17:84. doi: 10.1186/s13075-015-0595-4.

16.

Comparing Five Year Out-Come in Two Cohorts of Patients with Early Rheumatoid Arthritis - A BARFOT Study.

Andersson ML, Forslind K, Hafström I.

Open Rheumatol J. 2015 Feb 3;9:8-15. doi: 10.2174/1874312901409010008. eCollection 2015.

17.

Rheumatoid factor and anti-CCP do not predict progressive joint damage in patients with early rheumatoid arthritis treated with prednisolone: a randomised study.

Hafström I, Engvall IL, Rönnelid J, Boonen A, van der Heijde D, Svensson B; BARFOT study group.

BMJ Open. 2014 Jul 30;4(7):e005246. doi: 10.1136/bmjopen-2014-005246.

18.

Low-dose prednisolone treatment of early rheumatoid arthritis and late cardiovascular outcome and survival: 10-year follow-up of a 2-year randomised trial.

Ajeganova S, Svensson B, Hafström I; BARFOT Study Group.

BMJ Open. 2014 Apr 7;4(4):e004259. doi: 10.1136/bmjopen-2013-004259.

19.
20.

Low levels of antibodies against oxidized but not nonoxidized cardiolipin and phosphatidylserine are associated with atherosclerotic plaques in systemic lupus erythematosus.

Su J, Frostegård AG, Hua X, Gustafsson T, Jogestrand T, Hafström I, Frostegård J.

J Rheumatol. 2013 Nov;40(11):1856-64. doi: 10.3899/jrheum.121173. Epub 2013 Sep 15.

PMID:
24037548
21.

Long-term sustained remission in a cohort study of patients with rheumatoid arthritis: choice of remission criteria.

Svensson B, Andersson ML, Bala SV, Forslind K, Hafström I; BARFOT study group.

BMJ Open. 2013 Sep 10;3(9):e003554. doi: 10.1136/bmjopen-2013-003554.

22.

Disease factors in early rheumatoid arthritis are associated with differential risks for cardiovascular events and mortality depending on age at onset: a 10-year observational cohort study.

Ajeganova S, Andersson ML, Frostegård J, Hafström I.

J Rheumatol. 2013 Dec;40(12):1958-66. doi: 10.3899/jrheum.130365. Epub 2013 Aug 15.

PMID:
23950188
23.

Early increase in serum-COMP is associated with joint damage progression over the first five years in patients with rheumatoid arthritis.

Andersson ML, Svensson B, Petersson IF, Hafström I, Albertsson K, Forslind K, Heinegård D, Saxne T.

BMC Musculoskelet Disord. 2013 Aug 2;14:229. doi: 10.1186/1471-2474-14-229.

24.

Dr. Ajeganova and Dr. Hafström reply.

Ajeganova S, Hafström I.

J Rheumatol. 2013 Mar;40(3):337. No abstract available.

PMID:
23577349
25.

Low-dose prednisolone in early rheumatoid arthritis inhibits collagen type I degradation by matrix metalloproteinases as assessed by serum 1CTP--a possible mechanism for specific inhibition of radiological destruction.

Engvall IL, Svensson B, Boonen A, van der Heijde D, Lerner UH, Hafström I; BARFOT study group.

Rheumatology (Oxford). 2013 Apr;52(4):733-42. doi: 10.1093/rheumatology/kes369. Epub 2012 Dec 28.

PMID:
23275387
26.

Does digital X-ray radiogrammetry have a role in identifying patients at increased risk for joint destruction in early rheumatoid arthritis?

Forslind K, Kälvesten J, Hafström I, Svensson B; BARFOT Study Group.

Arthritis Res Ther. 2012 Oct 15;14(5):R219. doi: 10.1186/ar4058.

27.

Diet and fatty acid pattern among patients with SLE: associations with disease activity, blood lipids and atherosclerosis.

Elkan AC, Anania C, Gustafsson T, Jogestrand T, Hafström I, Frostegård J.

Lupus. 2012 Nov;21(13):1405-11. doi: 10.1177/0961203312458471. Epub 2012 Aug 28.

PMID:
22930204
28.

Carotid atherosclerosis, disease measures, oxidized low-density lipoproteins, and atheroprotective natural antibodies for cardiovascular disease in early rheumatoid arthritis -- an inception cohort study.

Ajeganova S, de Faire U, Jogestrand T, Frostegård J, Hafström I.

J Rheumatol. 2012 Jun;39(6):1146-54. doi: 10.3899/jrheum.111334. Epub 2012 May 15.

PMID:
22589258
29.

Association of obesity with worse disease severity in rheumatoid arthritis as well as with comorbidities: a long-term followup from disease onset.

Ajeganova S, Andersson ML, Hafström I; BARFOT Study Group.

Arthritis Care Res (Hoboken). 2013 Jan;65(1):78-87. doi: 10.1002/acr.21710.

30.

[Rheumatologic research with animal experiments is important for our patients].

Rudin A, Sturfelt G, Carlsten H, Hafström I, Lundberg I, Klareskog L, Rönnblom L, Jacobsson L, van Vollenhoven R, Rantapää-Dahlqvist S, Skogh T, Saxne T.

Lakartidningen. 2012 Jan 11-17;109(1-2):40. Swedish. No abstract available.

PMID:
22468412
31.

Microcirculation as determined by iontophoresis in SLE-patients and controls.

Anania C, Norman M, Heimburger M, Gustafsson T, Jogestrand T, Hafström I, Frostegård J.

Lupus. 2012 Jul;21(8):815-20. doi: 10.1177/0961203312439117. Epub 2012 Mar 13.

PMID:
22415927
32.

Effect of biological therapy on levels of atheroprotective antibodies against phosphorylcholine and apolipoproteins in rheumatoid arthritis - a one year study.

Ajeganova S, Fiskesund R, de Faire U, Hafström I, Frostegård J.

Clin Exp Rheumatol. 2011 Nov-Dec;29(6):942-50. Epub 2011 Dec 22.

PMID:
22153361
33.
34.

Longitudinal levels of apolipoproteins and antibodies against phosphorylcholine are independently associated with carotid artery atherosclerosis 5 years after rheumatoid arthritis onset--a prospective cohort study.

Ajeganova S, Ehrnfelt C, Alizadeh R, Rohani M, Jogestrand T, Hafström I, Frostegård J.

Rheumatology (Oxford). 2011 Oct;50(10):1785-93. doi: 10.1093/rheumatology/ker204. Epub 2011 Jul 9.

PMID:
21743088
35.

Late-onset neutropenia following rituximab therapy in rheumatic diseases: association with B lymphocyte depletion and infections.

Tesfa D, Ajeganova S, Hägglund H, Sander B, Fadeel B, Hafström I, Palmblad J.

Arthritis Rheum. 2011 Aug;63(8):2209-14. doi: 10.1002/art.30427.

36.

Low level of physical activity in women with rheumatoid arthritis is associated with cardiovascular risk factors but not with body fat mass--a cross sectional study.

Elkan AC, Håkansson N, Frostegård J, Hafström I.

BMC Musculoskelet Disord. 2011 Jan 14;12:13. doi: 10.1186/1471-2474-12-13.

37.

Treatment with low-dose prednisolone is associated with altered body composition but no difference in bone mineral density in rheumatoid arthritis patients: a controlled cross-sectional study.

Engvall IL, Brismar K, Hafström I, Tengstrand B.

Scand J Rheumatol. 2011 May;40(3):161-8. doi: 10.3109/03009742.2010.523012. Epub 2010 Nov 16.

PMID:
21077801
38.

Comprehensive rehabilitation of patients with rheumatic diseases in a warm climate: a literature review.

Forseth KO, Hafström I, Husby G, Opava C.

J Rehabil Med. 2010 Nov;42(10):897-902. doi: 10.2340/16501977-0632. Review.

39.
40.

Circulating proprotein convertase subtilisin kexin type 9 has a diurnal rhythm synchronous with cholesterol synthesis and is reduced by fasting in humans.

Persson L, Cao G, Ståhle L, Sjöberg BG, Troutt JS, Konrad RJ, Gälman C, Wallén H, Eriksson M, Hafström I, Lind S, Dahlin M, Amark P, Angelin B, Rudling M.

Arterioscler Thromb Vasc Biol. 2010 Dec;30(12):2666-72. doi: 10.1161/ATVBAHA.110.214130. Epub 2010 Sep 30.

PMID:
20884874
41.

Joint destruction in early rheumatoid arthritis over 8 years is similar in women and men despite apparently higher disease activity and poorer function in women.

Hafström I, Bala V, Albertsson K, Forslind K, Svensson B; BARFOT study group.

Ann Rheum Dis. 2011 Apr;70(4):709-10. doi: 10.1136/ard.2010.135343. Epub 2010 Aug 10. No abstract available.

PMID:
20699238
42.

Anti-apoA-1 IgG and oxidized LDL are raised in rheumatoid arthritis (RA): potential associations with cardiovascular disease and RA disease activity.

Vuilleumier N, Bratt J, Alizadeh R, Jogestrand T, Hafström I, Frostegård J.

Scand J Rheumatol. 2010 Nov;39(6):447-53. doi: 10.3109/03009741003742755. Epub 2010 Jul 6.

PMID:
20604674
43.

Increased expression of proto-oncogene survivin predicts Joint destruction and persistent disease activity in early rheumatoid arthritis.

Svensson B, Hafström I, Forslind K, Albertsson K, Tarkowski A, Bokarewa M.

Ann Med. 2010;42(1):45-54. doi: 10.3109/07853890903376280.

PMID:
20092399
44.

Hand bone loss measured by digital X-ray radiogrammetry is a predictor of joint damage in early rheumatoid arthritis.

Forslind K, Boonen A, Albertsson K, Hafström I, Svensson B; Barfot Study Group.

Scand J Rheumatol. 2009 Nov-Dec;38(6):431-8. doi: 10.3109/03009740902939376.

PMID:
19922017
45.

Self- and manual mobilization improves spine mobility in men with ankylosing spondylitis--a randomized study.

Widberg K, Karimi H, Hafström I.

Clin Rehabil. 2009 Jul;23(7):599-608. doi: 10.1177/0269215508101748. Epub 2009 Apr 29.

PMID:
19403551
46.

Rheumatoid cachexia, central obesity and malnutrition in patients with low-active rheumatoid arthritis: feasibility of anthropometry, Mini Nutritional Assessment and body composition techniques.

Elkan AC, Engvall IL, Cederholm T, Hafström I.

Eur J Nutr. 2009 Aug;48(5):315-22. doi: 10.1007/s00394-009-0017-y. Epub 2009 Mar 31.

PMID:
19333642
47.
48.

Gonadal hormones in men with rheumatoid arthritis--from onset through 2 years.

Tengstrand B, Carlström K, Hafström I.

J Rheumatol. 2009 May;36(5):887-92. doi: 10.3899/jrheum.080558. Epub 2009 Feb 27.

PMID:
19273455
49.

Influence of gender on assessments of disease activity and function in early rheumatoid arthritis in relation to radiographic joint damage.

Ahlmén M, Svensson B, Albertsson K, Forslind K, Hafström I; BARFOT Study Group.

Ann Rheum Dis. 2010 Jan;69(1):230-3. doi: 10.1136/ard.2008.102244.

PMID:
19158113
50.

Impact of low-dose prednisolone on bone synthesis and resorption in early rheumatoid arthritis: experiences from a two-year randomized study.

Engvall IL, Svensson B, Tengstrand B, Brismar K, Hafström I; Better Anti-Rheumatic FarmacO Therapy Study Group.

Arthritis Res Ther. 2008;10(6):R128. doi: 10.1186/ar2542. Epub 2008 Nov 5.

Supplemental Content

Loading ...
Support Center